Needleless Injection for Hospitals and Orthopedics
Home
Service Details
General Medicine Med-Jet MBX
Finger-lever Actuated Injector to Propel an Accurate and Adjustable dose of 0.02 up to 0.3cc.
Designed for a wide range of volume and depth of injections, making the MBX a versitile injector. A perfect injector for hospitals and orthopedic clinics.
Local Anesthesia
Minor surgeries
Mesotherapy
Clinical Dermatology
Podiatry
Cosmetic & Plastic Surgery
Physiatry & Pain management
Orthopedics
Reserve your needleless injector in the USA and Europe.
Reservations are now open for distribution in the United States and Europe, with an estimated launch in November 2024. For those in Canada, Korea, Japan, South Africa, Australia, New Zealand, Korea, Israel, Japan, Mexico, Kuwait, Thailand, and other Latin America locations, the Med-Jet MBX is already available for shipping. Contact us to check if your region is authorized for distribution. The Line of AGRO injectors are cleared and can be shipped today in the US and Europe.
General Medicine and Orthopedic use: Med-Jet MBX
MIT's Med-Jet MBX injector is a groundbreaking innovation in medical technology, offering unparalleled precision and versatility for a wide range of medical procedures. One of its standout features is its adjustable injection amount, which can be finely tuned from .02 cc's to 3.0 cc's, catering to diverse needs in hospitals, orthopedic practices, and general medicine. This flexibility makes it perfect for procedures such as bone marrow stem cell injections, sciatic nerve injections, arthritis treatments, and routine injections, among others.
The Med-Jet MBX injector is a game-changer in modern medical practice, offering doctors a tool that can cater to various medical needs with precision and efficiency. Whether it's for local anesthesia, deep injections, minor surgeries, or podiatry procedures, this injector provides doctors with the ability to perform these tasks with ease and accuracy.
Reservations for the Med-Jet MBX are currently open in the United States and Europe, with distribution set to begin in November 2024. For those in Canada, Africa, and Asia, the injector is already approved for shipping, with plans to expand distribution to other regions in the near future. Healthcare professionals interested in incorporating this innovative technology into their practice are encouraged to inquire about distribution authorization to ensure availability in their area.
The Med-Jet MBX injector embodies MIT's commitment to advancing medical technology and improving patient care. By providing doctors with a tool that offers pain-free injections and precise control over the injection process, MIT is revolutionizing the field of medicine. As more doctors start using needle-free injections, the Med-Jet MBX injector is poised to become an essential tool in modern medical practice, enhancing the efficiency and accuracy of injections across a wide range of medical procedures. Growing list of approved areas for sales and distribution: Canada; Korea; Japan; South Africa; Australia; New Zealand; Korea; Israel; Japan; South Africa; Mexico; Kuwait; Thailand; and other Latin America